treatment
PMA-stimulated PC-1 in patients with Type 2 diabetes was 17-times higher than in        controls, and was reduced to near the control level by 3-month metformin       treatment.
PMA-stimulated PC-1 in patients with Type 2 diabetes was 17-times higher than in        controls, and was reduced to near the control level by 3-month  @OBJECT$  @PREDICAT$  @SUBJECT$ .